Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab

View source ↗

Summary

A clinical trial investigating PSMA expression in glioblastoma after VEGF blockade with bevacizumab is currently NOT_YET_RECRUITING. The study aims to explore t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Royal North Shore Hospital | Conditions: Glioblastoma, Glioblastoma Multiforme (GBM) | Status: NOT_YET_RECRUITING